Chemotherapy-induced immunomodulation in non-small-cell lung cancer: A rationale for combination chemoimmunotherapy Journal Article
| Authors: | Zheng, H.; Zeltsman, M.; Zauderer, M. G.; Eguchi, T.; Vaghjiani, R. G.; Adusumilli, P. S. |
| Article Title: | Chemotherapy-induced immunomodulation in non-small-cell lung cancer: A rationale for combination chemoimmunotherapy |
| Abstract: | Spurred by the survival benefits seen with the use of checkpoint blockade in non-small-cell lung cancer (NSCLC), there has been a growing interest in the potential applications of immunotherapy. Despite this, the objective response rate for single-agent immunotherapy remains ≤20% in patients with advanced NSCLC. A combinatorial approach that utilizes both chemotherapy and immunotherapy is a potential strategy to increase antitumor efficacy. Accumulating evidence has shown that the immunomodulatory effects of chemotherapeutic agents can be exploited in a combinational approach. Herein, we review the influence of specific chemotherapeutic agents on the tumor immune microenvironment in preclinical and clinical studies, and establish the rationale for combination chemoimmunotherapy for the treatment of NSCLC. © 2017 Future Medicine Ltd. |
| Keywords: | chemotherapy; immunotherapy; immunomodulation; microenvironment; non-small-cell lung cancer |
| Journal Title: | Immunotherapy |
| Volume: | 9 |
| Issue: | 11 |
| ISSN: | 1750-743X |
| Publisher: | Future Medicine |
| Date Published: | 2017-09-01 |
| Start Page: | 913 |
| End Page: | 927 |
| Language: | English |
| DOI: | 10.2217/imt-2017-0052 |
| PROVIDER: | scopus |
| PMCID: | PMC5810850 |
| PUBMED: | 29338609 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 2 October 2017 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work